Hemostatic Management in Extracorporeal Membrane Oxygenation. Issue 2 (April 2022)

• Record Type: Journal Article
• Authors: Brokmeier, Hannah M.; Wieruszewski, Erin D.; Nei, Scott D.; Loftsgard, Theodore O.; Wieruszewski, Patrick M.
• Is Part Of: Critical care nursing quarterly. Volume 45:Issue 2(2022)
• Page Start: 132
• Page End: 143
• Publication Date: 2022-04
• Subjects: anticoagulation -- argatroban -- bivalirudin -- extracorporeal membrane oxygenation (ECMO) -- heparin; Critical care medicine -- Periodicals; Intensive care nursing -- Periodicals; Education, Nursing, Continuing -- Periodicals; Critical Care -- Periodicals; Emergencies -- Periodicals; 616.028
• DOI: 10.1097/CNQ.0000000000000396
• Languages: English
• ISSNs: 0887-9303

Abstract

Abstract : The use of extracorporeal membrane oxygenation (ECMO) for acute cardiac and/or respiratory failure has grown exponentially in the past several decades. Systemic anticoagulation is a fundamental element of caring for ECMO patients. Hemostatic management during ECMO walks a fine line to balance the risk of safe and effective anticoagulant delivery to mitigate thromboembolic complications and minimizing hemorrhagic sequelae. This review discusses the pharmacology, monitoring parameters, and special considerations for anticoagulation in patients requiring ECMO.